Edition:
India

Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

98.24SEK
7:30pm IST
Change (% chg)

0.54kr (+0.55%)
Prev Close
97.70kr
Open
97.38kr
Day's High
98.32kr
Day's Low
97.34kr
Volume
277,689
Avg. Vol
2,055,845
52-wk High
166.50kr
52-wk Low
79.14kr

Latest Key Developments (Source: Significant Developments)

Getinge Q1 operating result lags forecast
Thursday, 26 Apr 2018 

April 26 (Reuters) - Getinge AB ::Q1 ADJUSTED EBITA AMOUNTED TO SEK 301 M (485).Q1 ORDER INTAKE INCREASED ORGANICALLY BY 3.1%.Q1 NET SALES INCREASED ORGANICALLY BY 5.4%.Q1 OPERATING PROFIT (EBIT) AMOUNTED TO SEK -161 M (302), CURRENCY EFFECTS HAD A NEGATIVE IMPACT OF SEK -115 M ON EBIT.SAYS ORGANIC SALES GROWTH IS EXPECTED TO BE SLIGHTLY POSITIVE IN 2018.SAYS CURRENCY TRANSACTION EFFECTS ARE EXPECTED TO HAVE A NEGATIVE IMPACT OF APPROXIMATELY SEK -150 M (-100) ON THE GROUP’S 2018 EBIT.Q1 ORDER INTAKE 5,328 MILLION SEK.REUTERS POLL: GETINGE Q1 ORDER INTAKE WAS SEEN AT 5.4 BILLION SEK, OPERATING RESULT AT -62 MILLION.  Full Article

Getinge sets new financial targets after distribution of Arjo
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Getinge :Revised strategy, new financial targets and restated financial information for Getinge (excluding Arjo).Says ‍focus is on organic growth and Getinge foresees an organic market growth of 2-4% on average during 2017-2020 in addressable market​.Says ‍Getinge's organic growth in net sales is expected to increase gradually during 2018 and move closer to expected market growth on a run-rate basis by end of 2018​.Says targets ‍average growth in organic net sales: 2-4%​.Says ‍targets average earnings per share growth: >10%​.Says ‍dividend policy: 30-50% of net income.Getinge is distributing the Patient & Post-Acute Care business area​ into a separately listed company called Arjo.Says Arjo's shares of series B will be listed on Nasdaq Stockholm on December 12, 2017.  Full Article

Getinge Q3 core profit lags expectations, targets PPAC listing by year-end ​
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Getinge :Q3 ‍order intake increased by 2.2% to sek 7,334 m (7,176). Order intake increased organically by 4.7%.​.Getinge q3 - ‍net sales fell by 3.4% to sek 6,696 m (6,929). Net sales decreased organically by 0.7%.​.Q3 ‍ebita 1* declined by 31.6% to sek 659 m​.Getinge says organic sales growth is expected to be slightly positive in 2017.‍​.Getinge says currency transaction effects are expected to have a positive impact of approximately sek 250 m on getinge’s 2017 ebit‍​.Reuters poll: getinge q3 order intake was seen at 7.2 billion sek, adjusted. Ebita at 904 million.Says ‍net sales were adversely impacted by lower order intake in q2 and higher expenses partly related to work on preparing proposed distribution of patient & post-acute care business area​.Getinge says remainder of 2017 will be challenging, partly because the fourth quarter is our most important quarter in terms of sales and profitability, and partly because we have large-scale projects to complete before the start of 2018‍​.Getinge says aim is to distribute and list ppac division before end of year, on condition of a decision by the board and the approval of an extraordinary general meeting‍​.  Full Article

Getinge sees 2017 organic growth in lower half of 0-2 pct guidance range - CEO
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Getinge Ab CEO Mattias Perjos in conference call with analysts and media: :says sees f/y 2017 organic sales growth in lower half of 0-2 percent guidance range.  Full Article

UPDATE 1-Sweden's Getinge order book beat sends shares higher

STOCKHOLM, July 17 Swedish medical technology group Getinge reported stronger than expected orders thanks to a robust performance in capital goods and in emerging markets, sending its stock up more than 10 percent on Tuesday.